Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-03-02
1997-04-29
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514247, 514351, 514367, 514376, 514395, 514586, 544239, 546153, 546157, 546300, 548221, 548222, 5483064, 564 27, 564 29, A61K 3147, A61K 3144, C07D215227, C07D21536
Patent
active
056249373
ABSTRACT:
A compound of the formula I in which ##STR1## Z is O or S; R.sup.11 is a halogen atom;
REFERENCES:
Kempter G, Beerbalk HD (1983) Wiss. Z. Paedagog. Hochsch. "Karl Liebnecht" Potsdam 27(1) 101-20.
Haan J, Maat-Schieman ML. Roos RA (1994) Dementia 5 (3-4) 210-3. (Abstract).
U.S. application No. 08/398188, Heinz, et al., filed Mar. 2, 1995 (co-pending application).
Reel Jon K.
Simon Richard L.
Whitesitt Celia A.
Boone David E.
Eli Lilly and Company
Hay Martin A.
Huang Evelyn
Ivy C. Warren
LandOfFree
Chemical compounds as inhibitors of amyloid beta protein product does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chemical compounds as inhibitors of amyloid beta protein product, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemical compounds as inhibitors of amyloid beta protein product will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-705985